Based on actual market data, Renin-Angiotensin System (RAS) medicine sales in Chile showed a fluctuating trend. Between 2013 and 2023, sales experienced notable changes with significant year-on-year variations. In 2023, the sales value stood at 2.8 units. Over the past two years, the market saw an increase of 28% in 2022 followed by a 12.5% decrease in 2023. The Compound Annual Growth Rate (CAGR) over the last five years (2018-2023) averaged at 3.13%.

For future trends from 2024 to 2028, the forecast indicates a stable market with no expected growth, maintaining an annual sales volume of 2.8 units and a forecasted 5-year CAGR of 0%. Pointing towards market stabilization, companies need to watch for: